Reuters logo
BRIEF-Anhui Anke Biotechnology Group unit receives approval for drug clinical trials
July 7, 2017 / 2:53 PM / 5 months ago

BRIEF-Anhui Anke Biotechnology Group unit receives approval for drug clinical trials

July 7 (Reuters) - Anhui Anke Biotechnology Group Co Ltd :

* Says its unit has been granted approval for drug clinical trials for cefdinir tablets issued by China Food And Drug Administration

* Says it is mainly used for treatment of infect caused by Staphylococcus

Source text in Chinese: goo.gl/Bycasr

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below